A study involving 200 patients undergoing laparoscopic pancreatoduodenectomy demonstrated that 82.5% achieved a textbook outcome, indicating a smooth recovery without specified complications. Key independent risk factors included a higher likelihood for female patients and those with hard pancreatic texture. These findings suggest that specific patient characteristics can enhance the chances of achieving favorable surgical outcomes […]

Higher county-level provider density significantly correlates with lower hepatobiliary cancer incidence and mortality. Analysis across 1,359 counties revealed that areas with low provider density suffered higher rates of all-stage and late-stage cancer incidence, along with increased mortality rates. Notably, moderate and high provider density were linked to lower odds of these outcomes. The findings advocate […]

A multicenter study revealed that conversion surgery following FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy significantly improves overall survival in patients with initially unresectable pancreatic cancer. The surgery group demonstrated a median overall survival of 34.4 months, compared to 19.8 months in the control group (hazard ratio, 0.47). Postoperative complication rates were noted at 19.6%, with […]

CT-guided core needle biopsy (CNB) demonstrates high diagnostic yield and safety in pancreatic tumor evaluation. In a study of 43 biopsies across 42 patients, histological diagnosis was achieved in 93% of cases. CNB exhibited a sensitivity of 93%, specificity of 100%, and overall accuracy of 93%. No major complications arose during the procedures, with most […]

Findings indicate that older age at diagnosis of intraductal papillary mucinous neoplasms (IPMNs) correlates with a heightened long-term risk of pancreatic carcinoma. In a cohort of 3,142 IPMN patients, those aged 55-64, 65-74, and ≥75 exhibited adjusted subdistribution hazard ratios of 1.80, 2.56, and 3.31 respectively, compared to those under 55. These results suggest that […]